A genome-first multiomic approach to diagnosis
(feeds.feedburner.com)
1.
2.
Neurocrine to Buy Soleno for Treatment for Rare Disease That Causes Relentless Hunger
(feeds.content.dowjones.io)
3.
Neurocrine to Buy Soleno for $2.9 Billion
(feeds.content.dowjones.io)
4.
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
(feeds.content.dowjones.io)
5.
AI succeeds in diagnosing rare diseases
(feeds.nature.com)
6.
How DeepMind’s genome AI could help solve rare-disease mysteries
(feeds.nature.com)
7.
How DeepMind's genome AI could help solve rare disease mysteries
(feeds.nature.com)
Today's top topics:
android